Search Site

Sheng-Han Kuo, MD

  • Assistant Professor of Neurology
Sheng-Han Kuo, MD

Dr. Kuo is a Movement Disorders specialist caring for patients with ataxia, Parkinson's disease, and tremor. He also sees patients with dystonia, Tourette's syndrome, myoclonus, and chorea. His primary clinical interest is ataxia, including hereditary ataxias, neurodegenerative ataxias, and acquired causes of ataxia.

Dr. Kuo is a physician-scientist focusing on research of cerebellar diseases and Parkinson's disease. He has investigated the cerebellar changes in the post-mortem tissues of patients with essential tremor, and is involved in the natural history study and clinical trials of spinocerebellar ataxias. He has published articles in Neurology, Movement Disorders, and the Journal of Neuroscience. Dr. Kuo is a recipient of the American Academy of Neurology Research Fellowship Award and the Parkinson's Disease Foundation Lucien Côté Early Investigator Award in Clinical Genetics. 

Departmental Appointments

  • Department of Neurology
    Division of Movement Disorders

Languages Spoken

(in addition to English)

  • Chinese

Education & Training

  • National Taiwan University School of Medicine (Taiwan)
  • Internship: Baylor College of Medicine
  • Residency: Baylor College of Medicine

Committees/Societies/Memberships

Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA)

Tremor Research Group

American Academy of Neurology

Movement Disorders Society

Honors & Awards

Parkinson’s Disease Foundation Lucien Côté Early Investigator Award in Clinical Genetics

Louis V. Gerstner Jr. Scholar Award

American Academy of Neurology Research Fellowship

NIH Grants

  • A MODEL SYSTEM FOR STUDYING THE INTERACTION OF MULTIPLE PROCESSES FOR MOTOR LEARNING (Federal Gov)

    Sep 1 2013 - Aug 31 2018

    THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Federal Gov)

    Jul 1 2013 - Jun 30 2018

    PARKINSON S DISEASE FOUNDATION (PDF) RESEARCH CENTER GRANT (Private)

    Jul 1 2016 - Jun 30 2017

    VALIDATION OF CHAPERONE-MEDIATED AUTOPHAGY DYSFUNCTION AND GBA ACTIVITY IN GENETIC PD IPSC-DERIVED MDA NEURONS (Private)

    Feb 26 2016 - Apr 25 2017

    ABNORMAL CLIMBING FIBER - PURKINJE CELL SYNAPSES IN ESSENTIAL TREMOR (Private)

    Jul 1 2015 - Jun 30 2016

    PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)

    Jul 1 2000 - Jun 30 2016

    MECHANISMS OF SUBSTANTIA NIGRA NEURONAL DEATH IN PARKINSON S DISEASE (Private)

    Sep 1 2012 - Aug 31 2015

    THE ROLE OF EXCLOTOXICITY IN ESSENTIAL TREMOR CEREBELLUM (Private)

    Jul 1 2014 - Jun 30 2015

    PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)

    Jul 1 2000 - Jun 30 2015

    THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Private)

    Sep 1 2013 - Aug 31 2014

    MECHANISMS OF DOPAMINE NEURON DEGENERATION (Federal Gov)

    Aug 1 2000 - Jul 31 2014

    PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)

    Jul 1 2000 - Jun 30 2014

    PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)

    Jul 1 2000 - Jun 30 2014

    GLUCOCEREBROSIDASE AND MITOCHONDRIAL AUTOPHAGY IN DOPAMINERGIC NEURONS (Private)

    Jul 1 2011 - Sep 30 2013

    MUTANT GLUCOCEREBROSIDASE CAUSES DYSFUNCTIONAL CHAPERONE MEDIATED AUTOPHAGY AND ALPHA-SYNUCLEIN ACCUMULATION IN PATIENT FIBROBLAST- DERIVED DOPAMINERGIC NEURONS (Private)

    Jun 30 2012 - Aug 31 2013

    PARKINSON"S DISEASE FOUNDATION RESEARCH CENTER GRANT CLINICA L CORE (Private)

    Jul 1 2000 - Jun 30 2013